Free Trial

Celularity (CELU) Insider Trading & Ownership

Celularity logo
$2.76 -0.09 (-3.16%)
(As of 11/22/2024 ET)

Celularity (NASDAQ:CELU) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
20.70%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$5.35 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get CELU Insider Trade Alerts

Want to know when executives and insiders are buying or selling Celularity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CELU Insider Buying and Selling by Quarter

Celularity Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/12/2024Kok Thay LimMajor ShareholderBuy2,141,098$2.50$5,352,745.00  
(Data available from 1/1/2013 forward)

CELU Insider Trading Activity - Frequently Asked Questions

The list of insiders at Celularity includes Kok Thay Lim, and Robert J Hariri. Learn more on insiders at CELU.

20.70% of Celularity stock is owned by insiders. Learn more on CELU's insider holdings.

The following insiders have purchased CELU shares in the last 24 months: Kok Thay Lim ($5,352,745.00), and Robert J Hariri ($3,124,982.90).

Insiders have purchased a total of 3,988,309 CELU shares in the last 24 months for a total of $8,477,727.90 bought.

Celularity Key Executives

  • Dr. Robert Joseph Hariri M.D. (Age 65)
    Ph.D., Founder, CEO & Chairman
    Compensation: $1.24M
  • Mr. David C. Beers C.F.A. (Age 54)
    Chief Financial Officer
    Compensation: $455.02k
  • Mr. John R. Haines (Age 66)
    Senior EVP, Global Manager & Chief Administrative Officer
    Compensation: $503.56k
  • Ramji Krishnan
    Chief Technology Officer
  • Carlos Ramirez
    SVP of Investor Relations
  • Mr. Kyle Harold Fletcher Esq. (Age 39)
    Executive VP, General Counsel & Chief Compliance Officer
  • Dr. Stephen A. Brigido D.P.M. (Age 48)
    President of Degenerative Diseases
  • Dr. Adrian Kilcoyne M.B.A. (Age 53)
    M.D., M.P.H., Executive VP, Chief Medical Officer and Head of Global Affairs, Patient Safety & Patient Affairs
  • Sharmila Koppisetti M.D.
    Senior Vice President of Clinical Dev. Immunology & Drug Safety
  • Mr. Tim Wilk
    Senior Vice President of Technical Operations


This page (NASDAQ:CELU) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners